☆ 4.7 Article

The Local Anaesthetic Procaine Prodrugs ProcCluster® and Procaine Hydrochloride Impair SARS-CoV-2 Replication and Egress In Vitro

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Related references

Note: Only part of the references are listed.

Article Immunology

Efficacy of Early Treatment With Favipiravir on Disease Progression Among High-Risk Patients With Coronavirus Disease 2019 (COVID-19): A Randomized, Open-Label Clinical Trial

Chuan Huan Chuah et al.

Summary: Early treatment with oral favipiravir did not prevent disease progression from nonhypoxia to hypoxia in high-risk COVID-19 patients. No beneficial effects were observed in preventing mechanical ventilation, ICU admission, and in-hospital mortality.

CLINICAL INFECTIOUS DISEASES (2022)

Add to Collection

Article Cell Biology

A phase 2a clinical trial of molnupiravir in patients with COVID-19 shows accelerated SARS-CoV-2 RNA clearance and elimination of infectious virus

William A. Fischer et al.

Summary: In a clinical trial, the safety, tolerability, and antiviral efficacy of molnupiravir were evaluated in unvaccinated individuals with confirmed SARS-CoV-2 infection. The study found that participants receiving high-dose molnupiravir had a shorter time to viral RNA clearance and a lower detection rate of infectious virus. Molnupiravir was well tolerated across all doses.

SCIENCE TRANSLATIONAL MEDICINE (2022)

Add to Collection

Article Virology

SARS-CoV-2: Ultrastructural Characterization of Morphogenesis in an In Vitro System

Debora Ferreira Barreto-Vieira et al.

Summary: Researchers used various microscopy techniques to study the morphogenesis of SARS-CoV-2 in Vero-E6 cells and observed several ultrastructural changes. These findings contribute to understanding the infection mechanism of the virus and its similarities with other coronaviruses.

VIRUSES-BASEL (2022)

Add to Collection

Article Biology

Absolute quantitation of individual SARS-CoV-2 RNA molecules provides a new paradigm for infection dynamics and variant differences

Jeffrey Y. Lee et al.

Summary: Despite extensive research, early replication events of SARS-CoV-2 are still poorly understood. This study used smFISH to quantify viral RNA and found that SARS-CoV-2 genomic RNA has a long lifespan in cells and replication varies significantly between cells. Additionally, the B.1.1.7 variant exhibits slower replication kinetics than the Victoria strain, suggesting a novel mechanism contributing to its higher transmissibility.

ELIFE (2022)

Add to Collection

Article Chemistry, Medicinal

Emerging Vaccine-Breakthrough SARS-CoV-2 Variants

Rui Wang et al.

Summary: The surge of COVID-19 infections has been fueled by new SARS-CoV-2 variants. Understanding the molecular mechanism of SARS-CoV-2 transmission and evolution is crucial for predicting emerging vaccine-breakthrough variants and designing mutation-proof vaccines and monoclonal antibodies. This study integrates genotyping, antibody libraries, mutational data, topological data analysis, and deep learning to reveal the evolution mechanism of SARS-CoV-2 and forecast vaccine-breakthrough variants.

ACS INFECTIOUS DISEASES (2022)

Add to Collection

Article Multidisciplinary Sciences

SARS-CoV-2 nucleocapsid protein adheres to replication organelles before viral assembly at the Golgi/ERGIC and lysosome-mediated egress

Katharina M. Scherer et al.

Summary: This study investigates the dynamics of SARS-CoV-2 replication within cells by visualizing the spatiotemporal dynamics of the four structural proteins. It reveals the role of lysosomes in the egress of the virus and provides insights into the assembly process of SARS-CoV-2.

SCIENCE ADVANCES (2022)

Add to Collection

Article Pharmacology & Pharmacy

Nirmatrelvir Plus Ritonavir: First Approval

Yvette N. Lamb

Summary: Nirmatrelvir plus ritonavir is a medication developed for the treatment and post-exposure prophylaxis of COVID-19. It received authorization in the UK and EU for use in adults at high risk for severe COVID-19. Nirmatrelvir is an inhibitor of SARS-CoV-2 main protease, while ritonavir is a protease inhibitor and CYP3A inhibitor.

DRUGS (2022)

Add to Collection

Article Immunology

An updated overview of recent advances, challenges, and clinical considerations of IL-6 signaling blockade in severe coronavirus disease 2019 (COVID-19)

Reza Elahi et al.

Summary: This article reviews the role of IL-6 pathway in lung damage and ARDS in severe COVID-19 and discusses the rationale for IL-6 signaling blockade. Clinical data, challenges, and possible solutions are discussed, along with special clinical considerations for using different IL-6 inhibitors.

INTERNATIONAL IMMUNOPHARMACOLOGY (2022)

Add to Collection

Review Biochemistry & Molecular Biology

Replication of the coronavirus genome: A paradox among positive-strand RNA viruses

Emeline Grellet et al.

Summary: This article reviews the history of coronavirus replication and provides detailed information on the core replicative machinery of these viruses.

JOURNAL OF BIOLOGICAL CHEMISTRY (2022)

Add to Collection

Review Biochemistry & Molecular Biology

The life cycle and enigmatic egress of coronaviruses

Kristian Prydz et al.

Summary: There is significant interest in understanding the life cycle of SARS-CoV-2 and identifying potential targets for drug intervention. Although the exact mechanisms of how the virus is released from host cells are still unclear, several possible pathways have been proposed. This article provides an overview of the life cycle of coronaviruses, with a special focus on different routes for virus egress.

MOLECULAR MICROBIOLOGY (2022)

Add to Collection

Article Biochemistry & Molecular Biology

Nanopore ReCappable sequencing maps SARS-CoV-2 5 ' capping sites and provides new insights into the structure of sgRNAs

Camilla Ugolini et al.

Summary: The researchers used a new technique called NRCeq to identify the complete subgenomic RNAs of the SARS-CoV-2 virus and annotate the capping sites in the viral genome. They successfully obtained robust estimates of subgenomic RNA expression in cell lines and viral isolates, and discovered novel subgenomic RNA variants. These findings are of great importance to the scientific community.

NUCLEIC ACIDS RESEARCH (2022)

Add to Collection

Review Pharmacology & Pharmacy

JAK inhibition as a new treatment strategy for patients with COVID-19

Jin Huang et al.

Summary: The ongoing SARS-CoV-2 epidemic requires effective treatments for COVID-19, particularly severe pneumonia. Blocking the release of pro-inflammatory cytokines, predominantly through the JAK/STAT signaling pathway, shows promise in improving clinical outcomes. JAK inhibitors have the potential to control cytokine storms and are being explored in clinical trials for COVID-19 treatment.

BIOCHEMICAL PHARMACOLOGY (2022)

Add to Collection

Review Biochemistry & Molecular Biology

The double-membrane vesicle (DMV): a virus-induced organelle dedicated to the replication of SARS-CoV-2 and other positive-sense single-stranded RNA viruses

Philippe Roingeard et al.

Summary: Positive single-strand RNA (+ RNA) viruses can remodel host cell membranes to create a replication organelle (RO) that protects their genome replication from innate immunity. Certain viruses, such as severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2), induce double-membrane vesicles (DMVs) for this purpose. Understanding the mechanisms of DMV formation and their role in the infectious cycle of SARS-CoV-2 may be crucial for developing new antiviral strategies against this pathogen or future coronaviruses.

CELLULAR AND MOLECULAR LIFE SCIENCES (2022)

Add to Collection

Article Biochemistry & Molecular Biology

D,L-Lysine-Acetylsalicylate plus Glycine (LASAG) Reduces SARS-CoV-2 Replication and Shows an Additive Effect with Remdesivir

Johannes Jungwirth et al.

Summary: This study investigates the effects of the acetylsalicylic acid salt on SARS-CoV-2 infection and finds that it can inhibit viral replication and reduce inflammatory response. Interestingly, it also shows a synergistic effect when combined with the antiviral drug remdesivir.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Add to Collection

Article Medicine, Research & Experimental

The Two Sides of the Same Coin-Influenza Virus and Intracellular Signal Transduction

Stephan Ludwig et al.

Summary: Cells respond to viruses by activating signaling pathways for defense, which viruses can manipulate for their own replication. Targeting these pathways may offer new strategies for antiviral intervention.

COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2021)

Add to Collection

Review Pathology

Immunopathology of Hyperinflammation in COVID-19

Joshua N. Gustine et al.

Summary: The rapid spread of COVID-19 has led to an unprecedented global public health crisis with recent studies suggesting that the hyperinflammatory syndrome induced by SARS-CoV-2 is a contributing factor to disease severity and mortality. Pathophysiological research shows that the hyperinflammatory syndrome in severe COVID-19 results from a dysregulated innate immune response. Current potential therapeutic approaches are being investigated to modulate the immune response and mitigate lung injury in severe COVID-19.

AMERICAN JOURNAL OF PATHOLOGY (2021)

Add to Collection

Article Biochemistry & Molecular Biology

Genome-wide CRISPR Screens Reveal Host Factors Critical for SARS-CoV-2 Infection

Jin Wei et al.

Summary: Identification of essential host genes for SARS-CoV-2 infection, including ACE2 and Cathepsin L, and the discovery of pro-viral genes and pathways specific to SARS lineage and pan-coronavirus provide potential therapeutic targets and insights into pathogenesis of COVID-19. Small-molecule antagonists of these gene products inhibited SARS-CoV-2 infection across species, highlighting their conserved role in susceptibility to highly pathogenic CoVs.

CELL (2021)

Add to Collection

Article Biochemistry & Molecular Biology

SARS-CoV-2 infects cells after viral entry via clathrin-mediated endocytosis

Armin Bayati et al.

Summary: SARS-CoV-2 uses spike glycoprotein for initial interaction with cell surface and undergoes clathrin-mediated endocytosis, transferring viral RNA to cell cytosol. Knockdown of clathrin heavy chain reduces viral infectivity, highlighting the importance of clathrin-mediated endocytosis in virus infectivity.

JOURNAL OF BIOLOGICAL CHEMISTRY (2021)

Add to Collection

Article Cell Biology

ORF3a of SARS-CoV-2 promotes lysosomal exocytosis-mediated viral egress

Di Chen et al.

Summary: The study reveals that SARS-CoV-2 ORF3a promotes lysosomal exocytosis, enhancing viral release, while this mechanism is absent in SARS-CoV ORF3a. Specific residues are identified as crucial for promoting lysosomal exocytosis.

DEVELOPMENTAL CELL (2021)

Add to Collection

Letter Infectious Diseases

Clinical efficacy and safety of favipiravir in the treatment of COVID-19 patients

Ping-Jen Chen et al.

JOURNAL OF INFECTION (2021)

Add to Collection

Article Virology

Comparison of Subgenomic and Total RNA in SARS-CoV-2-Challenged Rhesus Macaques

Gabriel Dagotto et al.

Summary: Respiratory virus challenge studies aim to differentiate actively replicating virus from input challenge virus in the same anatomical locations. This study explores the potential utility of using subgenomic RNA to monitor actively replicating virus of SARS-CoV-2.

JOURNAL OF VIROLOGY (2021)

Add to Collection

Article Immunology

Untuned antiviral immunity in COVID-19 revealed by temporal type I/III interferon patterns and flu comparison

Ioanna-Evdokia Galani et al.

Summary: Andreakos and colleagues conducted a study comparing patients with COVID-19 and influenza, finding that COVID-19 patients exhibited a dysregulated interferon response with diminished and delayed interferon production compared to flu patients. In COVID-19 patients, pro-inflammatory cytokines were produced before interferons and persisted longer, leading to worsened clinical outcomes.

NATURE IMMUNOLOGY (2021)

Add to Collection

Review Biology

Why are some coronavirus variants more infectious?

Raju Mukherjee et al.

Summary: This review discusses the different types of prevalent SARS-CoV-2 variants, their emergence, mutations responsible for growth advantages, and their impact on vaccine efficacy. The focus is on the Alpha and Delta variants, with unclear effects and severity on human health. Efforts to monitor mutations and predict their impact are also summarized.

JOURNAL OF BIOSCIENCES (2021)

Add to Collection

Article Biochemistry & Molecular Biology

Evidence of escape of SARS-CoV-2 variant B.1.351 from natural and vaccine-induced sera

Daming Zhou et al.

Summary: The race to develop vaccines against SARS-CoV-2 variants, such as B.1.1.7, B.1.351, and P.1, is ongoing as these variants have mutations in the spike protein, potentially leading to immune escape. A structure-function analysis of B.1.351 revealed tighter ACE2 binding and widespread evasion from monoclonal antibody neutralization, particularly driven by the E484K mutation.

CELL (2021)

Add to Collection

Article Virology

SARS-CoV-2 Causes Severe Epithelial Inflammation and Barrier Dysfunction

Stefanie Deinhardt-Emmer et al.

Summary: SARS-CoV-2 efficiently infects epithelial cells and damages both epithelial and endothelial cells, resulting in barrier dysfunction that allows viral spread. The study demonstrates that viral-induced host factors disrupt the epithelial-endothelial barrier function and promote viral dissemination.

JOURNAL OF VIROLOGY (2021)

Add to Collection

Article Biochemistry & Molecular Biology

The SARS-CoV-2 subgenome landscape and its novel regulatory features

Dehe Wang et al.

Summary: Through next-generation sequencing, it was found that SARS-CoV-2 can generate diverse subgenomes through template switching. The majority of template switches result from RNA-RNA interactions, with terminal pairing status playing a key role.

MOLECULAR CELL (2021)

Add to Collection

Review Virology

SARS-CoV-2 Subgenomic RNAs: Characterization, Utility, and Perspectives

Samuel Long

Summary: SARS-CoV-2, the causative agent of the COVID-19 pandemic, has a large RNA genome that generates a tiered ensemble of subgenomic RNAs (sgRNAs). Comprehensive understanding of these RNA products is crucial for studying SARS-CoV-2 pathogenesis. Recent progress in identifying, characterizing, and utilizing SARS-CoV-2 sgRNAs as viral replication markers is discussed along with the significance of these findings and potential future research areas.

VIRUSES-BASEL (2021)

Add to Collection

Review Cell Biology

Assembly and Cellular Exit of Coronaviruses: Hijacking an Unconventional Secretory Pathway from the Pre-Golgi Intermediate Compartment via the Golgi Ribbon to the Extracellular Space

Jaakko Saraste et al.

Summary: This study explores the assembly of coronaviruses in the intermediate compartment at the ER-Golgi interface and their connection with the endocytic recycling system.

CELLS (2021)

Add to Collection

Review Microbiology

Innate immune and inflammatory responses to SARS-CoV-2: Implications for COVID-19

Shea A. Lowery et al.

Summary: Severe disease from COVID-19 is characterized by significant immunopathology driven by unbalanced innate immune response with limited and delayed interferon response, leading to excessive proinflammatory cytokine production and cellular infiltrates in the respiratory tract causing lung pathology. Effective therapeutics for severe COVID-19 patients depend on understanding the pathological elements of this dysregulated innate immune response, as well as identifying therapeutic strategies targeting these elements of the innate response.

CELL HOST & MICROBE (2021)

Add to Collection

Review Immunology

The Global Epidemic of the SARS-CoV-2 Delta Variant, Key Spike Mutations and Immune Escape

Dandan Tian et al.

Summary: The Delta variant of the SARS-CoV-2 virus, first reported in India in October 2020 and classified as a variant of concern by the WHO in May 2021, is highly transmissible and associated with increased hospitalization, ICU admission, and mortality rates. It has become the dominant strain in many countries globally.

FRONTIERS IN IMMUNOLOGY (2021)

Add to Collection

Review Immunology

When Immunity Kills: The Lessons of SARS-CoV-2 Outbreak

Yassine Taoufik et al.

Summary: SARS-CoV-2 has spread rapidly worldwide since the end of 2019, with most infected individuals experiencing mild or asymptomatic disease, while a minority, especially the elderly, may develop severe illness leading to ARDS. Specific T cell responses play a crucial role in virus clearance but may also contribute to the pathogenesis of ARDS.

FRONTIERS IN IMMUNOLOGY (2021)

Add to Collection

Article Biology

Early postmortem mapping of SARS-CoV-2 RNA in patients with COVID-19 and the correlation with tissue damage

Stefanie Deinhardt-Emmer et al.

Summary: COVID-19 is a systemic disease, and viral RNA distribution was found in both pulmonary and extrapulmonary tissues and organs, with high viral loads in the lungs. This supports the hypothesis of maladaptive host response with viremia and multiorgan dysfunction.

ELIFE (2021)

Add to Collection

Article Multidisciplinary Sciences

Correlative multi-scale cryo-imaging unveils SARS-CoV-2 assembly and egress

Luiza Mendonca et al.

Summary: In this study, Peijun Zhang and colleagues utilized advanced imaging techniques to study the infection process of SARS-CoV-2 in cells, revealing the lifecycle of the virus within the cell.

NATURE COMMUNICATIONS (2021)

Add to Collection

Review Microbiology

Cellular host factors for SARS-CoV-2 infection

Jim Baggen et al.

Summary: This review summarizes proviral host factors required for SARS-CoV-2 infection, important cellular processes in SARS-CoV-2 replication, and host factors that could be targeted for antiviral therapies for COVID-19.

NATURE MICROBIOLOGY (2021)

Add to Collection

Review Biochemistry & Molecular Biology

Metabolism pathways of arachidonic acids: mechanisms and potential therapeutic targets

Bei Wang et al.

Summary: The arachidonic acid (AA) pathway is crucial in cardiovascular biology, carcinogenesis, and various inflammatory diseases, producing bioactive mediators that are potential targets for cardiovascular diseases, cancers, and inflammatory diseases. This review summarizes the physiological and pathophysiological importance of AA metabolizing pathways, as well as the molecular mechanisms underlying its actions in CVD and cancer progression. Additionally, clinical studies targeting AA metabolisms in different disease conditions are introduced to explore the role of AA metabolism and potential therapies.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2021)

Add to Collection

Article Biochemistry & Molecular Biology

Cathepsin L plays a key role in SARS-CoV-2 infection in humans and humanized mice and is a promising target for new drug development

Miao-Miao Zhao et al.

Summary: CTSL plays a crucial role in COVID-19 patients, with its levels positively correlated with disease severity. Research showed that CTSL promotes SARS-CoV-2 virus entry into cells, and the CTSL inhibitor amantadine can inhibit this process, providing a direction for the development of new anti-COVID-19 drugs.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2021)

Add to Collection

Article Multidisciplinary Sciences

A new coronavirus associated with human respiratory disease in China

Fan Wu et al.

NATURE (2020)

Add to Collection

Article Multidisciplinary Sciences

Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2

Renhong Yan et al.

SCIENCE (2020)

Add to Collection

Article Biochemistry & Molecular Biology

Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19

Daniel Blanco-Melo et al.

CELL (2020)

Add to Collection

Article Microbiology

Heightened Innate Immune Responses in the Respiratory Tract of COVID-19 Patients

Zhuo Zhou et al.

CELL HOST & MICROBE (2020)

Add to Collection

Review Biochemistry & Molecular Biology

SARS-CoV-2 Inflammatory Syndrome. Clinical Features and Rationale for Immunological Treatment

Marcella Prete et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Add to Collection

Article Allergy

Type I IFN immunoprofiling in COVID-19 patients

Sophie Trouillet-Assant et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2020)

Add to Collection

Article Multidisciplinary Sciences

Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor

Jun Lan et al.

NATURE (2020)

Add to Collection

Article Multidisciplinary Sciences

A SARS-CoV-2 protein interaction map reveals targets for drug repurposing

David E. Gordon et al.

NATURE (2020)

Add to Collection

Article Hematology

Neutrophil extracellular traps contribute to immunothrombosis in COVID-19 acute respiratory distress syndrome

Elizabeth A. Middleton et al.

BLOOD (2020)

Add to Collection

Article Hematology

Platelet gene expression and function in patients with COVID-19

Bhanu Kanth Manne et al.

BLOOD (2020)

Add to Collection

Article Biochemistry & Molecular Biology

The Global Phosphorylation Landscape of SARS-CoV-2 Infection

Mehdi Bouhaddou et al.

CELL (2020)

Add to Collection

Article Cell & Tissue Engineering

Human Lung Stem Cell-Based Alveolospheres Provide Insights into SARS-CoV-2-Mediated Interferon Responses and Pneumocyte Dysfunction

Hiroaki Katsura et al.

CELL STEM CELL (2020)

Add to Collection

Article Cell & Tissue Engineering

Three-Dimensional Human Alveolar Stem Cell Culture Models Reveal Infection Response to SARS-CoV-2

Jeonghwan Youk et al.

CELL STEM CELL (2020)

Add to Collection

Article Multidisciplinary Sciences

Longitudinal analyses reveal immunological misfiring in severe COVID-19

Carolina Lucas et al.

NATURE (2020)

Add to Collection

Article Multidisciplinary Sciences

Exploring the SARS-CoV-2 virus-host-drug interactome for drug repurposing

Sepideh Sadegh et al.

NATURE COMMUNICATIONS (2020)

Add to Collection

Article Medicine, Research & Experimental

Distinct clinical and immunological features of SARS-CoV-2-induced multisystem inflammatory syndrome in children

Pui Y. Lee et al.

JOURNAL OF CLINICAL INVESTIGATION (2020)

Add to Collection

Article Biochemistry & Molecular Biology

β-Coronaviruses Use Lysosomes for Egress Instead of the Biosynthetic Secretory Pathway

Sourish Ghosh et al.

CELL (2020)

Add to Collection

Article Microbiology

Integrative Imaging Reveals SARS-CoV-2-Induced Reshaping of Subcellular Morphologies

Mirko Cortese et al.

CELL HOST & MICROBE (2020)

Add to Collection

Article Multidisciplinary Sciences

SARS-CoV-2 structure and replication characterized by in situ cryo-electron tomography

Steffen Klein et al.

NATURE COMMUNICATIONS (2020)

Add to Collection

Review Anesthesiology

Basic pharmacology of local anaesthetics

A. Taylor et al.

BJA EDUCATION (2020)

Add to Collection

Article Oncology

Procaine Inhibits the Proliferation and Migration of Colon Cancer Cells Through Inactivation of the ERK/MAPK/FAK Pathways by Regulation of RhoA

Chang Li et al.

ONCOLOGY RESEARCH (2018)

Add to Collection

Article Multidisciplinary Sciences

Phosphoproteomic-based kinase profiling early in influenza virus infection identifies GRK2 as antiviral drug target

Emilio Yanguez et al.

NATURE COMMUNICATIONS (2018)

Add to Collection

Review Biochemistry & Molecular Biology

Interaction of the innate immune system with positive-strand RNA virus replication organelles

Enzo Maxim Scutigliani et al.

CYTOKINE & GROWTH FACTOR REVIEWS (2017)

Add to Collection

Review Critical Care Medicine

Anti-inflammatory properties of anesthetic agents

Fernanda Ferreira Cruz et al.

CRITICAL CARE (2017)

Add to Collection

Article Virology

Severe Acute Respiratory Syndrome Coronavirus Replication Is Severely Impaired by MG132 due to Proteasome-Independent Inhibition of M-Calpain

Martha Schneider et al.

JOURNAL OF VIROLOGY (2012)

Add to Collection

Article Gastroenterology & Hepatology

Effect of Procainhydrochloride on Phospholipase A2 Catalytic Activity in Sodium Taurocholate-Induced Acute Experimental Pancreatitis in Rats

S. Kahl et al.

DIGESTIVE DISEASES (2010)

Add to Collection

Article Biochemistry & Molecular Biology

A possible role of lysophospholipids produced by calcium-independent phospholipase A2 in membrane-raft budding and fission

Takanari Nakano et al.

BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2009)

Add to Collection

Review Virology

A contemporary view of coronavirus transcription

Stanley G. Sawicki et al.

JOURNAL OF VIROLOGY (2007)

Add to Collection

Article Virology

Ultrastructure and origin of membrane vesicles associated with the severe acute respiratory syndrome coronavirus replication complex

Eric J. Snijder et al.

JOURNAL OF VIROLOGY (2006)

Add to Collection

Review Anesthesiology

Anti-inflammatory properties of local anesthetics and their present and potential clinical implications

J Cassuto et al.

ACTA ANAESTHESIOLOGICA SCANDINAVICA (2006)

Add to Collection

Article Anesthesiology

Time-dependent inhibition of G protein-coupled receptor signaling by local anesthetics

MW Hollmann et al.

ANESTHESIOLOGY (2004)

Add to Collection

Article Virology

Multiple enzymatic activities associated with Severe acute respiratory syndrome coronavirus helicase

KA Ivanov et al.

JOURNAL OF VIROLOGY (2004)

Add to Collection

Review Cell Biology

Phospholipase A2 (PLA2) enzymes in membrane trafficking:: Mediators of membrane shape and function

WJ Brown et al.

TRAFFIC (2003)

Add to Collection

Review Anesthesiology

Local anesthetics and the inflammatory response - A new therapeutic indication?

MW Hollmann et al.

ANESTHESIOLOGY (2000)

Add to Collection

© Peeref 2019-2024. All rights reserved.